SET is mainly located within the nucleus of the cells (Figure 1A); however, in many forms of cancers and neurodegenerative diseases, SET translocates from its primarly nuclear localization to the cytoplasm, where it can form an inhibitory interaction with PP2A. Here, PTPA is linked to cancer.